Hosted on MSN
GSK, CureVac to receive $740M as COVID vaccine patent dispute with Pfizer, BioNTech settled
CureVac (NASDAQ:CVAC) announced on Friday that the company and its partner, GSK (NYSE:GSK), are set to receive $740M and other payments, as Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have agreed to ...
CrowdStrike Holdings Inc. today announced plans to acquire startup SGNL Inc., which helps companies block unauthorized access to their systems. The transaction is worth $740 million. CrowdStrike, ...
Government ties cruise and MICE plans to long-term growth at Straits View. Singapore will invest $740m over the next five years to develop its tourism sector, as part of its Tourism 2040 strategy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results